Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images by �씠�듅援�
Multi-parametric tissue characterization of brain neoplasms and
their recurrence using pattern classification of MR images
Ragini Verma, Evangelia I. Zacharaki, Yangming Ou, Hongmin Cai, Sanjeev Chawla, Seung-
Koo Lee, Elias R. Melhem, Ronald Wolf, and Christos Davatzikos
Abstract
Rationale and Objectives: Treatment of brain neoplasms can greatly benefit from better
delineation of bulk neoplasm boundary and the extent and degree of more subtle neoplastic
infiltration. MRI is the primary imaging modality for evaluation before and after therapy, typically
combining conventional sequences with more advanced techniques like perfusion-weighted imaging
and diffusion tensor imaging (DTI). The purpose of this study is to quantify the multi-parametric
imaging profile of neoplasms by integrating structural MRI and DTI via statistical image analysis
methods, in order to potentially capture complex and subtle tissue characteristics that are not obvious
from any individual image or parameter.
Materials and Methods: Five structural MR sequences, namely, B0, Diffusion Weighted Images,
FLAIR, T1-weighted, and gadolinium-enhanced T1-weighted, and two scalar maps computed from
DTI, i.e., fractional anisotropy and apparent diffusion coefficient, are used to create an intensity-
based tissue profile. This is incorporated into a non-linear pattern classification technique to create
a multi-parametric probabilistic tissue characterization, which is applied to data from 14 patients
with newly diagnosed primary high grade neoplasms who have not received any therapy prior to
imaging.
Results: Preliminary results demonstrate that this multi-parametric tissue characterization helps to
better differentiate between neoplasm, edema and healthy tissue, and to identify tissue that is likely
progress to neoplasm in the future. This has been validated on expert assessed tissue.
Conclusion: This approach has potential applications in treatment, aiding computer-assisted
surgery by determining the spatial distributions of healthy and neoplastic tissue, as well as in
identifying tissue that is relatively more prone to tumor recurrence.
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1. Introduction
Treatment of brain neoplasms varies with their type, grade, location and extent, and often
includes a combination of surgical resection, and chemo-radiation. This can greatly benefit
from better delineation of bulk neoplasm boundary, as well as knowledge of the extent and
degree of neoplastic infiltration. The true boundary of many neoplasms is difficult to identify
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with conventional approaches, especially in gliomas which are diffuse and infiltrative.
Relatively advanced imaging strategies, such as perfusion weighted imaging (PWI), MR
spectroscopy (MRS) and diffusion tensor imaging (DTI), have improved evaluation in this
regard, but remain limited. Tissue characterization is difficult because neoplasms are often
heterogeneous, where different histopathologic grades can be present throughout an individual
neoplasm. Since the margin for error is relatively small in the brain, depending on location,
large portions of brain neoplasms may remain untreated or sub-optimally treated such that time
to recurrence shortens and prognosis worsens.
Clinical decisions regarding glioma treatments rely, in part, on MRI before and after surgery
as well as follow-up during and after chemo-radiation. Routine MRI sequences such as Fluid
Attenuated Inversion Recovery (FLAIR) and contrast enhanced T1-weighted MR images are
used to obtain estimates of enhancing and non-enhancing tissue, as well as of edema and/or
gliosis. However this process is time and labor intensive, susceptible to inter-rater variability,
and often inaccurate, especially in the setting of treatment related necrosis (TRN) versus
recurrence/progression. Clinical decision making has been aided by the efforts of the medical
image analysis community in developing MRI-based automated tumor detection and
segmentation [1-9].
A simplified view of a brain neoplasm includes enhancing neoplasm/tumor (ET) tissue and
non-enhancing tissue (NET) (solid tissue), and edema (diffuse tissue). As the manifestation of
each of these tissue types varies across subjects and has different underlying pathological
substrates depending on the neoplasm type, there has been growing interest in image-based
objective identification of these tissue types as well as possible infiltration. For example, a
combination of T1 (with and without IV contrast), T2 and PD-weighted images have been used
in a fuzzy clustering framework to segment ET [6] and NET [5]. FLAIR images show
infiltrating neoplasm and edema with relatively high contrast. Non-conventional imaging
protocols, such as diffusion weighted imaging (DWI) and cerebral blood volume (CBV) maps
calculated from PWI, have demonstrated the ability to discriminate between high and low grade
neoplasms and also to study prognosis or predict outcome but are non-specific in identifying
tumor boundary [10-12].
DTI [13] has been used for determining fiber tract deformation as a result of neoplasm growth
[14-17], as well as to study the progression or infiltration of the neoplasm along white matter
tracts [18,19]. Some studies have used anisotropy and diffusivity information provided by
fractional anisotropy (FA) and apparent diffusion coefficient (ADC) maps computed from DTI
data for differentiation of infiltrating neoplasm and edema [14,18-21]. DTI metrics have also
shown potential in discriminating tumor recurrence from radiation-induced necrosis [22].
A few key issues are apparent with regard to the potential of multi-parametric MRI in studying
brain tumors. First, while individual MR modalities provide information about some aspects
of the tumor, no single modality is capable of providing a comprehensive tissue
characterization. Properly combining such diverse MR protocols is likely to enhance
discriminatory power and specificity, and to better highlight the extent and degree of tumor
infiltration. Second, tissue characterization that reveals the degree and extent of infiltration is
important for tumor characterization in addition to bulk tumor segmentation; however, little
has been done to identify the likelihood of recurrence in the tissue surrounding the neoplasm,
based on multi-parametric imaging. Third, most of the methods developed have not used
advanced pattern classification techniques to discern the patterns of tissue types and infiltration
or increase the objectivity of interpretation. .
The current work proposes a multi-parametric neoplastic tissue characterization that
incorporates high dimensional intensity features created from multiple MRI acquisition
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protocols (structural MRI as well as DTI) into a pattern classification framework, to obtain a
voxel-wise probabilistic spatial map called a Tissue Abnormality Map that reflects the
likelihood that a given voxel (spatial location) is healthy tissue, tumor, edema, neoplastic
infiltration or a combination thereof. Moreover, by using machine learning methods guided by
the follow-up scans, the likelihood of a region presenting tumor recurrence after treatment is
determined. By evaluating patients with several different high grade brain neoplasms and using
expert interpretation as a standard, it is demonstrated that such probabilistic tissue
characterization is able to better differentiate between neoplastic infiltration, edema and
healthy tissue than any single MR modality. More generally, it has been able to produce a
subtle characterization of tumor tissue and surrounding tissue, and identify regions that later
present recurrence. The accuracy of segmentation has been assessed on samples provided by
experts. This study is one of the first to investigate integration of multiple MRI parameters via
sophisticated nonlinear pattern classification methods to obtain a better characterization of the
tumor and the surrounding tissue, as well as to investigate imaging profiles of tissue that are
relatively more likely to present tumor recurrence in follow-up scans.
2. Methods
We propose a multi-parametric framework for tissue classification and production of
probabilistic maps of tissue abnormality and tumor recurrence. Intensity based features
computed from expert-defined training samples are integrated via a pattern classification
technique into a multi-parametric imaging profile that aims at classifying brain tissue into each
of the following classes: enhancing tumor (ET), non-enhancing tumor (NET), edema (ED),
white matter (WM), gray matter (GM) and cerebro-spinal fluid (CSF). This multi-parametric
tissue profile for neoplasms using pre-operative imaging can be extended to post-operative
follow up scans to determine regions that demonstrate high likelihood of tumor recurrence.
2.1 Data Acquisition
We used two datasets, one for creating and validating the tissue abnormality map and the other
for generating the recurrence map. In the former, we only have scans of one time point, and in
the latter, we have longitudinal scans, across several time points, before and after surgery.
2.1.1 Creation of Tissue Abnormality Map—The population studied consisted of fifteen
patients with newly diagnosed primary high grade brain tumors (eight grade 3 and seven grade
4) who had not received any therapy prior to imaging. The MR data for each patient were
acquired either on a 3T Scanner (Siemens, Trio) or on a 1.5T (GE Medical Systems, Genesis
Trio) scanner, under an IRB approved protocol which was HIPAA compliant; the scanner
assignment was random (not related to any patient characteristics). The following sequences
were acquired: T1-weighted (T1) (256×192×160, resolution .9765×.9765×1, TR:1620, TE:
3.87), T2 (512×512×19, resolution .4297×..4297×6.5, TR:4000, TE: 85), FLAIR
(256×256×46, resolution .9375×.9375×3, TR:1000, TE: 147), gadolinium-enhanced T1-
weighted (GAD) (256×256×46, resolution .9375×.9375×3, TR:1000, TE: 147) and Diffusion
Tensor Imaging (DTI) (128×128×40, resolution:1.72×1.72×3.0, 12 gradient directions). Since
studies were not always performed on the same scanner because of workflow constraints, there
was some variation in TR, TE etc. However special effort was made to make the protocols
highly comparable across scanners, in order to avoid introducing confounding variability in
the images. For creating the multi-parametric tissue profile we used five structural MR
acquisition protocols, namely, diffusion-weighted and baseline images (DWI and B0,
respectively), FLAIR, T1, and, GAD and two scalar maps computed from the diffusion tensor
images: FA and ADC [13]. Fig. 1 shows representative slices from each of the acquisition
protocols.
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2.1.2 Creation of recurrence maps—The cases chosen are representative of tumor
recurrence as a result of tumor infiltration into surrounding healthy tissue or due to incomplete
resection. Our framework focuses on these ambiguous regions that have a mixture of neoplastic
and normal tissue characteristics with the aim of classifying them to one of these two classes
of normal and neoplastic tissue. The selection of the patients followed three criteria:
(a) no evidence for residual enhancing tumor existed after the first resection (based on the
clinical reports created by examining the postoperative images acquired within the same
day);
(b) the patients have shown obvious recurrence confirmed by pathology and a second
craniotomy; and
(c) all of the 7 MR protocols (required for the multi-parametric tissue profile discussed
above) were available in the pre-resection stage; not all protocols were required in the
post-resection stage. Specifically, the search in the post-resection images for regions with
characteristics of recurrence was mostly based on visual evaluation of FLAIR, T2 and
GAD images, and CBV maps (computed from perfusion images). The CBV maps help
distinguish between radiation treatment effects and tumor recurrence. None of the images
from the post-resection scans (including CBV maps) were used in the training for creating
the multi-parametric profile (probabilistic map).
Of the available brain tumor cases, 3 cases met all the above criteria and have been included.
2.2 Preprocessing
The images are skull stripped and smoothed using the public software package FSL [23]. For
each of the patients, all the modalities are rigidly co-registered to the T1-weighted image using
FSL's registration algorithm, called FLIRT [24] (rigid registration suffices as it is within the
same patient). Data is made comparable across patients using histogram matching of intensities.
In order to create the feature vectors, we fuse information from the same voxel across different
imaging protocols of the same person. In order to extend the profile to a recurrence map, we
register the follow-up (post-resection) images to the pre-resection image using deformable
registration [25], as non-linear deformations are introduced due to the relaxation of tumor mass
effect. The co-registration of all temporal images is important to keep track of changes that
reflect tumor progression and for mapping the region of tumor recurrence from the post- to the
pre-operational space.
2.3 Design of Tissue Abnormality Feature Vector
We define voxel-wise intensity features using the aligned and pre-processed MR images. The
intensity feature vector for each voxel  in the 3D image volume I, is defined by concatenating
all 7 image values:
where  denotes the intensity of image of modality M at voxel  . These feature vectors are
defined at each voxel in the training samples. In order to render this feature vector more robust
to noise, we incorporate neighborhood information by using four of its neighbors. 7
dimensional intensity features for these 5 voxels are stacked into a long vector (35
dimensional), which is then used as a feature vector.
2.3.1 Selection of the training samples—Training samples are identified by an expert
neuroradiologist (co-author) by delineating small portions of the tumor tissue types of ET, NET
and ED, using the FLAIR and GAD-T1 images. The training samples for ET, NET and ED are
picked very conservatively (only those that have a high certainty according to the expert) as
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demarcated in red in Fig. 2 (columns 1 and 2). We obtain training samples for the healthy tissue
by automatically segmenting the healthy portion of the brain into three classes: WM, GM and
CSF using a k-means segmentation algorithm provided by FSL, called FAST [26], excluding
regions close to the tumor. By segmenting the healthy portion of the brain during training we
are able to build a different model for each of the WM, GM and CSF classes, and therefore
avoid the repeated application of a segmentation method, like FAST, to all new coming brain
tumor images. It may be noted that the algorithm is being designed to emulate the knowledge
of the expert and hence depends on the expert's definition of the regions. Using multiple experts
will increase the size of training samples and is expected to lead to better classifiers. However,
conflicting regions of definitions between the experts indicate areas with low certainty about
the tissue type and therefore need to be removed from the definition prior to using them as
training samples.
2.3.2 Creation of Tissue Classifiers and Tissue Probability Maps—We investigated
several pattern classification techniques that are available in the literature that can help create
tissue classifiers. We found that linear multivariate pattern classification techniques such as
PCA (Principal Component Analysis) are easier to apply but they create “global” features for
each class that are insufficiently representative for discriminating one tissue class from another,
especially when the difference between two classes is very subtle, which will be the case in
tumor components (NET and ED) and in infiltration. SVM (Support Vector Machines) [27]
were found to optimally classify the data into two or more classes [28,29]. We construct two
kinds of classifiers using two different non-linear classification strategies optimized for the
respective application: 1) Intra-patient classifier: Bayesian classifiers [30] trained using expert
defined training samples from within a single patient; and 2) Inter-patient classifier: SVM
classifiers trained by combining samples from several patients. For the purposes of comparison,
Bayesian classifiers are also constructed using data from several patients. Validation of the
classifiers is done by creating classifiers using only part of the expert defined training samples,
and then applying the classifiers to those excluded samples to determine how well the
classification agrees with the expert's interpretation [27]. The amount of agreement is referred
to as the classification accuracy.
Intra-patient classification: We use Bayesian classification method, to design discriminant
functions [30] for each of the 6 tissue classes for a subject, that we refer to as the respective
tissue class classifiers. Different discriminant functions designed for each of the 6 tissue
classes, i.e. ET, NET, ED, WM, GM and CSF, evaluated at each voxel, provide the estimate
of the probability of that voxel belonging to the respective class, and produce a 3D voxel-wise
probability map, called Tissue Abnormality Map. There is one Tissue Abnormality Map
pertaining to each of the 6 tissue classifiers produced by assuming multivariate Gaussian
distribution for the features. We can obtain tissue segmentation by assigning the voxel to the
class having the highest discriminant value, among the six classes. This method of tissue
classification is optimal when training samples are available for the patient whose tissue needs
to be characterized. It effectively replicates the experts' samples to identify regions that are
similar. However, only tissue classes (ET, ED, NET) identified by the expert can be
characterized for that patient, and due to the conservative nature of sample selection, may not
reflect the presence of the alternate tissue types for which no expert identification was provided.
This requires pooling samples from several patients and due to the high variability across
individuals, Bayesian classification with its multinomial Gaussian assumption does not provide
adequate classification.
Inter-patient classification: We combine training samples from across patients, to obtain a
more generalized tissue classification using SVM. We define 6 classifiers, one pertaining to
each of healthy (WM, GM and CSF) and neoplasm (ET, NET and ED) classes [27]. Each
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classifier is created using two sets of training samples, one containing samples of the tissue
type for which the classifier is being created, and the second class containing samples from all
other tissue classes combined together. This is referred to the one-versus-all framework of
creating a classifier and details can be found in [27]. When these classifiers are applied to
features defined at voxels in a new brain, they produce a number (SVM classification score)
indicative of the class membership (tissue type). This SVM score is then converted to a pseudo-
probability score p_platt using Platt's method [31]. Then the probability values are normalized:
p_normalized = p_platt /sum(p), where sum(p) is the sum of platt probabilities for all classes.
These voxel-wise pseudo-probability scores form the Tissue Abnormality Map pertaining to
that classifier. Responses from the classifiers are combined to obtain tissue segmentation, i.e.
labels are assigned according to the maximum probability (after normalization). The classifiers
are validated using a similar framework to the one adopted in intra-patient classification.
2.4 Design of Recurrence Map
Fig. 3 provides examples of recurrence maps for 3 cases. The top row shows slices from post-
resection scans: CBV maps computed from perfusion images and T1 images (with/without
contrast) that indicate regions of likelihood of recurrence characterized by increased
enhancement in GAD (cases 2, 3) and high CBV (case 2) or hypointensity in T1 (case 1, 3),
which are regions indicative of high risk (indicated by green arrows). Visual cues gathered
from these scans were combined with the cues obtained by elastically registering the post-
resection scans with the pre-resection scans (shown in bottom row, left) to account for tissue
deformation caused by resection, and to guide the determination of the position of these
probable recurrence regions in the pre-resection scans (marked in burgundy in bottom row).
Since no evidence for residual enhancing tumor existed after the resection, these regions were
likely to be on or outside the visible tumor boundary pre-resection and developed abnormality
over time possibly due to tumor infiltration. Samples for the healthy class depicted in blue (Fig.
3, bottom row) were delineated close to the tumor as well as away from it, in order to sample
the variability fully. These samples were used to train a two class SVM classifier. At each
instance of training, one patient was left out. Then the classifiers, applied to this left-out patient,
produced voxel-wise SVM scores of the tissue at that voxel demonstrating recurrence. These
voxel-wise SVM scores comprise a recurrence probability map that is indicative of the voxel-
wise likelihood of recurrence.
3. Results
The experiments were conducted with the aim of identifying the applicability of the multi-
parametric framework in distinguishing between neoplastic tissue types in patients and
identifying regions that have a high likelihood of recurrence. In all these experiments, our aim
was to produce 3D voxel-wise spatial probability maps for each tumor tissue type, however
we have also produced maps of hard segmentation in order to validate the results visually and
empirically. We use classification rates and sensitivity and specificity values, computed on
some of the expert defined samples excluded from training, to provide a measure of degree of
certainty in identifying the tumor and the healthy tissue. Classification rate is the percentage
of correctly classified voxels with respect to the total number of training voxels available for
that class. Therefore, there is one value for each of the 6 class. We take the average over all
the subjects for that class to produce the average values for each of the classes.
The sensitivity and specificity are calculated on the two-class problem by grouping together
the tumorous tissue types ED, ET and NET into one class (positive class) and the healthy tissue
types CSF, GM, WM into an other class (negative class), respectively. The sensitivity and
specificity show the percentage of correctly classified positive and negative samples
respectively. Sensitivity = TP*100 / (TP + FN) and Specificity = TN*100 / (FP + TN) where
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TP, TN, FN, FP stand for true positive, true negative, false negative and false positive
respectively.
3.1 Intra-patient Tissue Classification
Figure 2 shows the results of applying the Bayesian classification framework (section 2.3.2)
on 3 of the 14 patients. Each row corresponds to a different patient and shows examples of
expert-defined neoplastic regions that are used as training samples, the tissue probability maps,
as well as hard tissue segmentation obtained from these probability maps. The top left corner
of each probability map gives the classification accuracy for that tissue in that patient. For some
patients, where the expert was unable to define certain tissue types, such as NET in rows 2 and
3 of Fig. 2, no probability maps could be created. The average classification rates over all
datasets can be found in row 1 of Table 1.
3.2 Inter-patient tissue classification
The comparative results of applying the inter-patient, Bayesian and SVM, tissue classifiers can
be found in Table 1, row 2 and 3, respectively. As can be observed, Bayesian classification
(row 2) performed poorly in the inter-patient framework, i.e., in the case of increased variability
in the data, due to the combination of training samples from several patients, as compared with
the intra-patient Bayesian classification (row 1).
By combining the training samples from different patients, we can combine information from
patients within a grade and apply to other patients of the same grade. Empirically, we found
that keeping within the grade produces probability maps that are high in specificity. The
average sensitivity and specificity for all patients can be found in the last columns of Table 1.
For visual assessment, we show the application of the inter-patient tissue classifiers on a case
with non-enhancing tumor (Fig. 4) and on a case with enhancing tumor (Fig. 5). The first
column in both figures provides slices from the FLAIR and GAD image to indicate the extent
and composition of the tumor. The top row 1 (column 2 – 4 for Fig. 4 and column 3 – 6 for
Fig. 5) shows the probability maps and tissue segmentation map obtained by applying the SVM
classifiers (section 2.3.2) to this patient and the bottom row the Bayesian classifier (created
using training samples from all patients except this patient). The comparative classification
rates and sensitivity and specificity for these patients are given in Table 2. In Fig. 4, there was
no ET detected in the tumor, the NET was over-segmented by the Bayesian framework (as is
also evident from the tissue probability maps for NET which shows high false positives). The
entire tumor was classified as NET failing to detect the tissue differences. The SVM framework
was able to characterize the tumor as a combination of edema and NET and the dark core was
classified as CSF, perhaps due to the nature of the tissue. In Fig. 5, we see the example of a
case in which the Bayesian framework provides better segmentation, which is also reflected
in the classification accuracy in Table 2. However SVM performs better in determining healthy
tissue with low false positives.
3.2 Analyzing Patterns of Tumor Recurrence
As explained in section 2.4, recurrence classifier created from two patients was then applied
to the features computed from the pre-resection scans of the third patient, to create a recurrence
probability map, indicative of regions with high likelihood of recurrence. Fig. 3, bottom row,
right, shows the recurrence probability maps for three cases. Although these results are
preliminary and the number of patients is very small to be able to draw a conclusion, it can be
observed that regions that were identified as recurrence in these patients, actually showed high
probability (red) of abnormality in the pre-resection scans.
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4. Discussion
In this study we have created a multi-parametric profile for brain tumors, aiming at a
comprehensive tissue characterization. Both classification approaches (intra- and inter-patient
with Bayesian and SVM classification) have the same underlying framework, namely
combining conventional structural MRI with DTI, to train classifiers for the tumor types of
enhancing and non-enhancing tumor, edema and healthy tissue. The distinction of the
neoplastic tissue from healthy tissue, as well as the identification of different tumor components
and edema, as can be seen in Figs. 4-5, indicates that this multi-parametric framework
effectively integrates multi-protocol information into a comprehensive tissue profile that can
systematically evaluate the extent and heterogeneous composition of the tumor, and accurately
replicate the expert's outlining of these regions. Thus, knowing the probable extent of
abnormality of the neoplasm in terms of enhancing or non-enhancing tumor type or edema,
will help better target the treatment of these regions. Existing computerized methods for
diagnosis suffer from the absence of validation due to the lack of ground truth. Conventionally,
histopathological exam following a biopsy has been the accepted ground truth. However its
outcome depends on the region sampled and given the heterogeneity of the tumor, may wrongly
indicate the grade of the tumor and the subsequent treatment. The probability measures of our
framework are defined on each voxel, and therefore capture heterogeneous patterns of tissue
pathology. Moreover, these maps may provide sufficient premise to histologically test regions
with higher probability of neoplastic content. This would aid in making clinical decisions.
Indeed, tissue that shows mixture of healthy and neoplastic tissue, with or without edema, may
be a precursor to the development of a neoplasm in the future. This is precisely the aim of the
experiments that we have conducted on cases that have demonstrated recurrence (Fig. 3). By
identifying regions in the pre-resection scan that correspond to the recurring neoplasms in the
follow-up scans, we have characterized the imaging profile of abnormal tissue that transformed
to a neoplasm. Although we have used a small dataset for the identification of regions of high
abnormality and high tumor recurrence probability, the quantification of the degree of
abnormality by the probability maps in this manner illustrates the concept of anticipating sites
of recurrence requiring more aggressive or alternate therapies. Thus, although we might not
always have accurately determined the regions of recurrence, we have been able to demonstrate
that the regions we predicted to recur, based on the probabilistic maps produced by the
classification framework, did actually progress to recurrence.
We have proposed intra- and inter- patient approaches to the characterization of neoplastic
tissue, based on very conservative training samples identified by experts. The approach that is
to be finally adopted depends on the application. If the aim is to replicate the understanding of
the expert for a particular patient, as may be the case in a surgery-related decision, then the
intra-patient Bayesian framework is the best (as can be seen in the classification rates and the
good segmentation maps in Fig. 2). While useful for individual patient analysis, such a profile
can only be applied to future scans of that patient alone, owing to the fact that the profile will
not be able to capture the variability across patients. An analysis of the probability and the
segmentation maps reveals that the framework tends to over-segment tissue types (such as ET
in patient of row 1 and edema in patient of row 2, in Fig.2). Additionally, the intra-patient
Bayesian framework is unsuitable for determining a tissue type that the expert is unable to
identify, or even do the characterization of the patient for which no training samples are
available. This is especially the case when there is a large mass of NET and edema which is
difficult to distinguish even by the expert. When treatment decisions need to be made about
surrounding non-enhancing tissue, it is important to have a tissue characterization that will
highlight the regions of abnormality. This was the motivation to develop the inter-patient
framework.
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The evaluation of the SVM and Bayesian classification methods in combining tissue samples
across patients, indicates SVM performs better. A comparison of row 2 and 3 of Table 1 shows
that the Bayesian classifier has lower sensitivity than the SVM, and also demonstrates increased
classification accuracy (with lower variability) for the SVM classifier in all tissue types except
NET. Edema identification shows marked improvement. ET is also identified with high
classification accuracy based on the expert defined samples. The comparison reveals that NET
was the most difficult tissue type to characterize both by the computerized algorithm as well
as the experts, demonstrated by the fact that the expert identified the least training samples for
NET. This is indicative of the variability in these regions across patients. There is a decrease
in the average classification rate of NET from the inter-patient Bayesian to the SVM
classification, although both are low, which could be due to the low number of training samples
to which SVM is sensitive. Based on the improved performance in the other tissue classes, we
expect SVM to do better when we add training samples in the future. While it may seem that
the intra-patient Bayesian classification performs very well in the case of NET, it should be
noted that this is only true for patients in whom NET has already been identified by an expert
and the average classification rates have been computed only on these few subjects. Analysis
of the NET classification results with inter-patient classification reveals that it is mostly mis-
classified as edema, GM and CSF or a possible combination of these. This could be explained
by the fact that NET could have healthy tissue combined with neoplasm and edema and NET
could be easily mis-classified by an expert too. The superiority of inter-patient classification
reveals that a combination of information from several patients is crucial for generalizability
when a new patient is to be tested in this framework. We propose to use additional features
and better SVM based classifiers to pursue inter-patient classification of tumor types.
Conclusions
In summary, we have tested a multi-parametric framework for neoplastic tissue
characterization using multiple MR acquisition protocols. This abnormality profile helps
distinguishing between neoplastic components, edema and normal tissue, and creating a
probabilistic map that indicates the likelihood of tumor recurrence. We expect that our tissue
classification will be able to 1) provide a better understanding of the spatial distribution of
cancer, thereby assisting in treatment planning either via resection or focused radiotherapy and
radiosurgery; 2) potentially enhance the physician's ability to diagnose and segment the tumor
and 3) help identifying tissue that can convert to tumor in follow up cases post resection. The
method can thus potentially be used to study tissue changes introduced as a result of
radiotherapy, chemotherapy and medication. Future studies are necessary to provide a more
extensive training basis for the classifiers, and to further validate the performance of this
computer analysis methodology. We also propose to use feature selection schemes to determine
the contribution of each of the modalities, so that the modalities best for tissue characterization
can be identified and the acquisition protocol streamlined.
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Fig. 1.
A representative slice from each of the seven co-registered MR modalities used in creating the
multimodality tissue profile.
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Fig. 2.
Intra-patient Bayesian classification framework applied to 3 patients. Each row corresponds
to a patient. Columns 1 – 2 show examples of conservative training samples chosen by the
expert for tissues samples of ED, ET and/or NET. Columns 3 – 5 are the probability maps for
ED, NET and ET, respectively. The numbers in the upper left corners denote the classification
rates. A missing image such as in (2, 4) block indicates the lack of training samples for that
tissue class and hence the inability of the classifier to produce the corresponding probability
map. The color bar for the probability maps are in block (2, 4). Column 6 shows the segmented
image with the color coding of the tissues shown next to the color bar.
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Fig. 3.
Maps of tumor recurrence for three cases. For each case, the top row shows post-resection
scans; green arrows point to regions identified as suspected of possible recurrence. Bottom
row, left: Pre-resection scans showing the regions used for training; blue are samples for healthy
tissue; burgundy are some of the regions identified by an expert as having recurrence in post-
resection scans when combined with cues obtained from elastic registration. Bottom row, right:
Probability maps using inter-patient classifiers that provide a voxel-wise map of likelihood of
tumor recurrence. The color bar is the same as that of Fig. 2 with red indicating higher degree
of abnormality. Red arrows are used to indicate regions in which recurrence actually occurred
in follow-up scans.
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Fig. 4.
Application of SVM classification (top row) and Bayesian classification (bottom row) of the
neoplasm represented in column 1 by training across patients. While SVM classifiers
combining information from several patients are able to identify both ED and NET, like the
expert, the Bayesian classifiers created from this patient alone identify the whole neoplastic
region as NET (unlike the expert). The color-coding is same as that of Fig. 2.
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Fig. 5.
Application of SVM classification (top row) and Bayesian classification (bottom row) of the
neoplasm represented in column 1 by training across patients using training samples shown in
column 2. The SVM classification (top row, column 3–6) is more conservative than the
Bayesian classification (bottom row, column 3–6) and matches the expert better. The
probability maps using the Bayesian classification seem to identify the edema well, over-
segment the ET and confuse the NET with CSF. The SVM classification is able to capture the
presence of NET (green) in the segmented image on top row, along with ED and ET. The color-
coding is same as that of Fig. 2.
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